HomeTRAW • NASDAQ
add
Traws Pharma Inc
Previous close
$8.06
Day range
$7.05 - $9.31
Year range
$4.06 - $24.75
Market cap
26.60M USD
Avg Volume
1.09M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 57.00K | 0.00% |
Operating expense | 8.59M | 66.98% |
Net income | -8.48M | -78.84% |
Net profit margin | -14.87K | -78.84% |
Earnings per share | — | — |
EBITDA | -8.53M | -67.86% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 5.41M | -78.57% |
Total assets | 8.94M | -66.95% |
Total liabilities | 10.97M | -12.40% |
Total equity | -2.03M | — |
Shares outstanding | 3.03M | — |
Price to book | -12.03 | — |
Return on assets | -154.51% | — |
Return on capital | -1,049.68% | — |
Cash Flow
Net change in cash
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Net income | -8.48M | -78.84% |
Cash from operations | -11.48M | -156.79% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 0.00 | — |
Net change in cash | -11.48M | -155.88% |
Free cash flow | -8.28M | -188.74% |
About
Founded
1998
Website
Employees
18